Can a new eye injection preserve vision in south asians with diabetes?

This trial tests whether faricimab, an eye injection, can improve vision and reduce swelling in South Asian patients with diabetic macular edema (DMO), a complication of diabetes that can lead to blindness. Previous studies mostly included Caucasian or East Asian participants, leaving a gap for South Asians who have higher rates of diabetes and DMO. The study will follow 120 UK-based South Asian adults for up to 88 weeks, using a treat-and-extend approach where the time between injections is adjusted based on response. The goal is to see if faricimab provides meaningful vision gains, durable control of retinal swelling, and a safe profile in this specific population.